Indicaton

PHELINUN® 200 mg (melphalan) as conditioning treatment prior to allogeneic haematopoietic stem cell transplantation in haematological diseases.

Therapeutic indications
Type of product
Table
  • Phase
    Marketed
  • Available in
    EU, GB